Rasagiline alone and in combination with riluzole prolongs survival in an ALS mouse model

Journal of Neurology
Stefan WaibelA Ludolph

Abstract

Rasagiline is an antiapoptotic compound with neuroprotective potential. We examined its neuroprotective effect alone and in combination with the putative glutamate release blocker riluzole in the G93A model of familial amyotrophic lateral sclerosis (fALS). Endpoints of experimental treatment were survival and motor activity. The drug had a significant dose-dependent therapeutic effect on both preclinical and clinical motor function and survival of the animals. We also found that the combination of rasagiline with riluzole is safe and increases survival by about 20 % in a dose-dependent manner. Therefore, we conclude that the combination of rasagiline and riluzole is a promising clinical combination for the improvement of current neuroprotective treatment strategies of ALS.

Associated Clinical Trials

Jun 17, 2013·Albert Christian Ludolph, Prof.

Citations

May 28, 2009·Journal of Neurology·Gregor K Wenning, Nadia Stefanova
Jan 26, 2010·Antioxidants & Redox Signaling·Orly WeinrebMoussa B H Youdim
Oct 21, 2011·Journal of Neurophysiology·J E SchusterC J Heckman
Aug 16, 2006·Neuro-degenerative Diseases·Albert C Ludolph, A-D Sperfeld
Jun 21, 2011·PloS One·Jesse A SolomonMazen J Hamadeh
Jun 3, 2010·Clinical Interventions in Aging·Julie Leegwater-Kim, Elena Bortan
May 23, 2015·Neurology and Therapy·Michele PistacchiSandro Zambito Marsala
Aug 3, 2011·Expert Opinion on Emerging Drugs·Ali Aamer Habib, Hiroshi Mitsumoto
Oct 4, 2005·Expert Opinion on Pharmacotherapy·Olivier Rascol
Aug 21, 2013·Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration·Erin J McAllumPeter J Crouch
Jul 27, 2007·Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases·Albert C LudolphUNKNOWN ENMC Group for the Establishment of Guidelines for the Conduct of Preclinical and Proof of Concept Studies in ALS/MND Models
Jul 12, 2008·Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases·Steven J Del SignoreRobert J Ferrante
Nov 1, 2013·Drug Discovery Today·Bariş Genç, P Hande Özdinler
Jul 6, 2010·Progress in Neurobiology·Orly WeinrebMoussa B H Youdim
Jan 29, 2008·Experimental Neurology·Nadia StefanovaGregor K Wenning
Feb 16, 2007·Neurobiology of Disease·Michael Benatar
Apr 3, 2015·Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration·Zachary MacchiUNKNOWN Western ALS (WALS) Rasagiline Study Group
Dec 17, 2008·Movement Disorders : Official Journal of the Movement Disorder Society·Robert A HauserUNKNOWN TEMPO Open-label Study Group
Nov 29, 2007·Pharmacotherapy·Hubert H Fernandez, Jack J Chen
Jun 23, 2015·Journal of Neurochemistry·Andréia C K Fontana
Jul 22, 2005·Lancet Neurology·Sivakumar Sathasivam, Pamela J Shaw
Jan 13, 2015·Annals of Clinical and Translational Neurology·Michael R JablonskiPiera Pasinelli
Sep 2, 2014·Brain Research·Michael JablonskiDavide Trotti
Sep 11, 2014·Drug Discovery Today·Yongjin ZhuXin Wang
Feb 11, 2015·Clinical Therapeutics·Monica BucchiaStefania Corti
May 5, 2016·Neurobiology of Disease·Stefanie RauskolbMichael Sendtner
Jul 4, 2016·European Journal of Medicinal Chemistry·Vijay KumarFaizan Ahmad
Mar 10, 2017·Expert Opinion on Investigational Drugs·Ana MartinezCarmen Gil
Sep 1, 2009·Therapeutic Advances in Neurological Disorders·Albert C Ludolph, Sarah Jesse
Oct 4, 2007·The Neuroscientist : a Review Journal Bringing Neurobiology, Neurology and Psychiatry·Carmen Villmann, Cord-Michael Becker
Dec 10, 2017·Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration·Marion C HoggJochen H M Prehn
Sep 8, 2018·Muscle & Nerve·Jeffrey M StatlandUNKNOWN Rasagiline Investigators of the Muscle Study Group and Western ALS Consortium
Sep 1, 2011·Retina·Sylvie Eigeldinger-BerthouGian-Marco Sarra
Mar 23, 2006·Nature Reviews. Neuroscience·Moussa B H YoudimKeith F Tipton
Jul 19, 2013·Cellular and Molecular Life Sciences : CMLS·Rachna S PandyaXin Wang
Feb 27, 2015·Reviews in the Neurosciences·Dibbanti HarikrishnareddyBikash Medhi
Aug 9, 2007·Drugs·Vicki OldfieldCaroline M Perry
Apr 6, 2017·Frontiers in Cellular Neuroscience·Roberta Bonafede, Raffaella Mariotti
Dec 20, 2020·Nature Reviews. Neurology·Matthew C KiernanMartin R Turner
Feb 18, 2020·Neuropharmacology·Adriano ChiòGabriele Mora
May 22, 2009·Biochemistry·Rossen ApostolovHaruki Nakamura

❮ Previous
Next ❯

Related Concepts

Related Feeds

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS) is associated with the death of neurons that control voluntary muscles. This feed followes the latest research into therapies for this progressive neurodegenerative disease.

Amyloid Lateral Sclerosis

Amyotrophic Lateral Sclerosis (ALS) is a progressive nervous system disease associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.